Literature DB >> 26797267

Lipid Accumulation Product and Hypertension Related to Stroke: a 9.2-Year Prospective Study Among Mongolians in China.

Chongke Zhong1, Wei Xia, Xiaoyan Zhong, Tian Xu, Hongmei Li, Mingzhi Zhang, Aili Wang, Tan Xu, Yingxian Sun, Yonghong Zhang.   

Abstract

AIMS: We aimed to assess the relationship between lipid accumulation product (LAP) and stroke incidence and whether increased LAP would further enlarge the risk of stroke in participants with hypertension in an Inner Mongolian population of China.
METHODS: Based on the baseline survey conducted in 2002-2003, a prospective cohort study was conducted among 2547 Mongolian people from Inner Mongolia, China. LAP was calculated by waist circumference (WC) and triglyceride (TG) concentration for men and women, respectively. Cox proportional hazards models and receiver operating characteristic (ROC) curves were used to evaluate the associations between LAP, hypertension, and stroke incidence.
RESULTS: During the follow-up period, a total of 121 stroke events were observed. Participants with higher LAP were associated with higher risk of stroke [adjusted hazard ratio (HR), 1.67; 95% confidence interval (CI), 1.08-2.58] than the participants in the lower LAP group. However, no significant dose-response relationship was detected between LAP levels and risk of stroke (P-trend=0.103). The Kaplan-Meier curves showed that hypertensives with high LAP had highest cumulative stroke incidence rate (log-rank P <0.001). The multivariate-adjusted HRs (95% CIs) of stroke for normotensives with high LAP, hypertensives with low LAP, and hypertensives with high LAP were 1.80 (0.84-3.89), 2.94 (1.51-5.74), and 4.23 (2.15-8.34), respectively, compared with normotensives with low LAP.
CONCLUSIONS: The present study showed that high LAP was associated with an increased risk of future stroke, and hypertensives with high LAP had the highest risk of stroke among Inner Mongolians. These findings indicate that LAP and hypertension may be valuable to predict and prevent stroke incidence.

Entities:  

Mesh:

Year:  2016        PMID: 26797267     DOI: 10.5551/jat.33514

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  8 in total

1.  Fatty Liver Index and Lipid Accumulation Product Can Predict Metabolic Syndrome in Subjects without Fatty Liver Disease.

Authors:  Yuan-Lung Cheng; Yuan-Jen Wang; Keng-Hsin Lan; Teh-Ia Huo; Yi-Hsiang Huang; Chien-Wei Su; Wei-Yao Hsieh; Ming-Chih Hou; Han-Chieh Lin; Fa-Yauh Lee; Jaw-Ching Wu; Shou-Dong Lee
Journal:  Gastroenterol Res Pract       Date:  2017-01-17       Impact factor: 2.260

2.  Lipid accumulation product is a powerful tool to predict non-alcoholic fatty liver disease in Chinese adults.

Authors:  Haijiang Dai; Weijun Wang; Ruifang Chen; Zhiheng Chen; Yao Lu; Hong Yuan
Journal:  Nutr Metab (Lond)       Date:  2017-08-01       Impact factor: 4.169

3.  Pravastatin Reduces the Risk of Atherothrombotic Stroke when Administered within Six Months of an Initial Stroke Event.

Authors:  Naohisa Hosomi; Yoji Nagai; Kazuo Kitagawa; Yoko Nakagawa; Shiro Aoki; Tomohisa Nezu; Tatsuo Kagimura; Hirofumi Maruyama; Hideki Origasa; Kazuo Minematsu; Shinichiro Uchiyama; Masayasu Matsumoto
Journal:  J Atheroscler Thromb       Date:  2017-09-16       Impact factor: 4.928

4.  Evaluation of the Association between Obesity Markers and Type 2 Diabetes: A Cohort Study Based on a Physical Examination Population.

Authors:  Tengfei Yang; Bo Zhao; Dongmei Pei
Journal:  J Diabetes Res       Date:  2021-12-28       Impact factor: 4.011

5.  Association Between Lipid Accumulation Product and Cognitive Function in Hypertensive Patients With Normal Weight: Insight From the China H-type Hypertension Registry Study.

Authors:  Yanyou Xie; Junpei Li; Guotao Yu; Xinlei Zhou; Wei Zhou; Lingjuan Zhu; Tao Wang; Xiao Huang; Huihui Bao; Xiaoshu Cheng
Journal:  Front Neurol       Date:  2022-02-03       Impact factor: 4.003

6.  Curcumin Offers No Additional Benefit to Lifestyle Intervention on Cardiometabolic Status in Patients with Non-Alcoholic Fatty Liver Disease.

Authors:  Kaveh Naseri; Saeede Saadati; Zahra Yari; Behzad Askari; Davood Mafi; Pooria Hoseinian; Omid Asbaghi; Azita Hekmatdoost; Barbora de Courten
Journal:  Nutrients       Date:  2022-08-06       Impact factor: 6.706

7.  Factors Associated with Intima-Media Complex Thickness of the Common Carotid Artery in Japanese Noncardioembolic Stroke Patients with Hyperlipidemia: The J-STARS Echo Study.

Authors:  Shinichi Wada; Masatoshi Koga; Kazunori Toyoda; Kazuo Minematsu; Masahiro Yasaka; Yoji Nagai; Shiro Aoki; Tomohisa Nezu; Naohisa Hosomi; Tatsuo Kagimura; Hideki Origasa; Kenji Kamiyama; Rieko Suzuki; Toshiho Ohtsuki; Hirofumi Maruyama; Kazuo Kitagawa; Shinichiro Uchiyama; Masayasu Matsumoto
Journal:  J Atheroscler Thromb       Date:  2017-11-08       Impact factor: 4.928

8.  Interaction of lipid accumulation product and family history of hypertension on hypertension risk: a cross-sectional study in the Southern Chinese population.

Authors:  JunXuan Huang; XinYu Bao; YiXian Xie; XiaoXia Zhang; Xin Peng; Yan Liu; MengJiao Cheng; JinXiang Ma; PeiXi Wang
Journal:  BMJ Open       Date:  2019-11-28       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.